New drug trial aims to breach Cancer's defenses
Disease control
Recruiting now
This early-stage study is testing a new drug called PRTH-101, both alone and combined with an existing immunotherapy (pembrolizumab), in adults with advanced or metastatic solid tumors. The main goals are to find a safe dose, see how the body processes the drug, and check for ear…
Phase: PHASE1 • Sponsor: Incendia Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC